Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Performance of serum CD163 as a marker of fibrosis in patients with NAFLD

3 Dec 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal health and immunology
Share to Liver Disease Diagnosis and Treatment
Share to Metabolomics and Mass Spectrometry Studies

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33310266
DOI: 10.1016/j.dsx.2020.11.023

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Performance of serum CD163 as a marker of fibrosis in patients with NAFLDPMID 33310266Read ↗

Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and CSemantic proximity Read ↗

Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitisSemantic proximity Read ↗

The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson's disease.Semantic proximity Read ↗

FibroMAX™: towards a new universal biomarker of liver disease?Semantic proximity Read ↗

The macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients.Semantic proximity Read ↗

Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinomaSemantic proximity Read ↗

Machine Learning Soft Voting Algorithm for Prediction and Detection of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

The Clinical Significance of the CD163+ and CD68+ Macrophages in Patients with Hepatocellular CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.